KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non Operating Investment Income (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Non Operating Investment Income for 4 consecutive years, with -$10.0 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Non Operating Investment Income rose 25.03% year-over-year to -$10.0 million, compared with a TTM value of -$54.8 million through Dec 2023, down 2.8%, and an annual FY2025 reading of -$16.4 million, up 43.07% over the prior year.
  • Non Operating Investment Income was -$10.0 million for Q4 2023 at Ginkgo Bioworks Holdings, up from -$36.3 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $12.6 million in Q1 2021 and bottomed at -$38.7 million in Q2 2022.
  • Average Non Operating Investment Income over 4 years is -$9.2 million, with a median of -$6.4 million recorded in 2023.
  • The sharpest move saw Non Operating Investment Income crashed 13642.22% in 2021, then skyrocketed 94.52% in 2023.
  • Year by year, Non Operating Investment Income stood at -$90000.0 in 2020, then tumbled by 16068.89% to -$14.6 million in 2021, then rose by 8.23% to -$13.4 million in 2022, then increased by 25.03% to -$10.0 million in 2023.
  • Business Quant data shows Non Operating Investment Income for DNA at -$10.0 million in Q4 2023, -$36.3 million in Q3 2023, and -$2.1 million in Q2 2023.